Andy holds a B.A. from Harvard University, and earned his M.A. and PhD in genetics from Columbia University. While at Columbia, Andy was a fellow at the Technology Ventures office, focusing on out-licensing discoveries from Columbia labs. After graduate school, Andy worked in sell-side equity research at Stifel focusing in the biotechnology sector. Andy joined the Avoro Capital team in 2015 and is primarily involved in evaluating platform technologies and early clinical development programs.
+1 212.937.4970